Excela Reciprocal RRG
Major Rating Factors:
Poor long-term capitalization index (0.7 on a scale of 0 to 10) based on weak current risk adjusted capital (severe and moderate loss scenarios). Weak overall results on stability tests (0.0) including weak risk adjusted capital in prior years and weak risk diversification. The largest net exposure for one risk is excessive at 43.5% of capital. Fair reserve development (4.7) as the level of reserves has at times been insufficient to cover claims. In 2021 and 2020 the two year reserve development was 38.5% and 39.1% deficient respectively.
Other Rating Factors:
Fair profitability index (4.0) with operating losses during 2020. Return on equity has been low, averaging 1.8% over the past five years. Vulnerable liquidity (2.9) as a spike in claims may stretch capacity.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
D - Limited diversification of general business, policy, and/or investment risk.
G - Fast asset or premium growth.
Principal Lines of Business:
Med mal (94.6%), other (5.4%)
Licensed in:
VT
Principal Investments:
Cash (7.0%), other (93.0%)
Corporate Info
Group Affiliation
None
Investment Rating
--
Company Address
463 Mountain View Drive
Colchester, VT 05446
Colchester, VT 05446
Phone Number
(802) 864-5599
NAIC Number
15337
Website
--
Largest Affiliates
No affiliate information available.